{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:13:26Z","timestamp":1769818406290,"version":"3.49.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000650","name":"Institute of Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000650","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.clbc.2022.02.012","type":"journal-article","created":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T11:52:16Z","timestamp":1646135536000},"page":"e636-e640","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Isotope-Only Localization for Sentinel Lymph Node Biopsy - Medium-Term Oncological Outcomes"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7757-1643","authenticated-orcid":false,"given":"Aikaterini","family":"Micha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Asad","family":"Parvaiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liz","family":"O'Riordan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"MacNeill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0967-1778","authenticated-orcid":false,"given":"Jennifer E","family":"Rusby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2022.02.012_bib0001","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.ejso.2018.02.186","article-title":"Isotope-only localisation of sentinel lymph node biopsy; medium-term oncological outcome","volume":"44","author":"Micha","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clbc.2022.02.012_bib0002","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archsurg.1992.01420040034005","article-title":"Technical details of intraoperative lymphatic mapping for early stage melanoma","volume":"127","author":"Morton","year":"1992","journal-title":"Arch Surg"},{"key":"10.1016\/j.clbc.2022.02.012_bib0003","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1148\/radiol.2282020651","article-title":"Lymphatic mapping in patients with breast carcinoma: reproducibility of lymphoscintigraphic results","volume":"228","author":"Tanis","year":"2003","journal-title":"Radiology"},{"key":"10.1016\/j.clbc.2022.02.012_bib0004","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/bcr281","article-title":"History of sentinel node and validation of the technique","volume":"3","author":"Tanis","year":"2001","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.clbc.2022.02.012_bib0005","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/00000658-199409000-00015","article-title":"Lymphatic mapping and sentinel lymphadenectomy for breast cancer","volume":"220","author":"Giuliano","year":"1994","journal-title":"Ann Surg"},{"key":"10.1016\/j.clbc.2022.02.012_bib0006","doi-asserted-by":"crossref","first-page":"7703","DOI":"10.1200\/JCO.2005.08.001","article-title":"American society of clinical oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer","volume":"23","author":"Lyman","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2022.02.012_bib0007","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1200\/JCO.2016.71.0947","article-title":"Sentinel lymph node biopsy for patients with early-stage breast cancer: American society of clinical oncology clinical practice guideline update","volume":"35","author":"Lyman","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2022.02.012_bib0008","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/PPO.0000000000000090","article-title":"Sentinel lymph node biopsy in breast cancer: a work in progress","volume":"21","author":"Chatterjee","year":"2015","journal-title":"Cancer J"},{"key":"10.1016\/j.clbc.2022.02.012_bib0009","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S1470-2045(07)70278-4","article-title":"Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial","volume":"8","author":"Krag","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clbc.2022.02.012_bib0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/cncr.21568","article-title":"Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis","volume":"106","author":"Kim","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2022.02.012_bib0011","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jnci\/djj158","article-title":"Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial","volume":"98","author":"Mansel","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2022.02.012_bib0012","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1002\/bjs.6721","article-title":"Sentinel lymph node biopsy in breast cancer guided by indocyanine green fluorescence","volume":"96","author":"Murawa","year":"2009","journal-title":"Br J Surg"},{"key":"10.1016\/j.clbc.2022.02.012_bib0013","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.breast.2014.01.004","article-title":"The Central-European SentiMag study: sentinel lymph node biopsy with superparamagnetic iron oxide (SPIO) vs. radioisotope","volume":"23","author":"Thill","year":"2014","journal-title":"Breast"},{"key":"10.1016\/j.clbc.2022.02.012_bib0014","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/bjs.5211","article-title":"Randomized clinical trial comparing blue dye with combined dye and isotope for sentinel lymph node biopsy in breast cancer","volume":"92","author":"Hung","year":"2005","journal-title":"Br J Surg"},{"key":"10.1016\/j.clbc.2022.02.012_bib0015","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejso.2009.01.008","article-title":"Association of Breast Surgery at B. Surgical guidelines for the management of breast cancer","volume":"35","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clbc.2022.02.012_bib0016","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.ejso.2004.08.003","article-title":"Blue dye versus combined blue dye-radioactive tracer technique in detection of sentinel lymph node in breast cancer","volume":"30","author":"Radovanovic","year":"2004","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clbc.2022.02.012_bib0017","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S1081-1206(10)60921-0","article-title":"Anaphylaxis to isosulfan blue and cross-reactivity to patent blue V: case report and review of the nomenclature of vital blue dyes","volume":"96","author":"Scherer","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.clbc.2022.02.012_bib0018","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.0105-1873.2005.0407c.x","article-title":"Anaphylaxis to patent blue during sentinel lymph node identification","volume":"53","author":"van Zuuren","year":"2005","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clbc.2022.02.012_bib0019","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1308\/003588408X285702","article-title":"Atypical anaphylactic reaction to patent blue during sentinel lymph node biopsy for breast cancer","volume":"90","author":"Lanitis","year":"2008","journal-title":"Ann R Coll Surg Engl"},{"key":"10.1016\/j.clbc.2022.02.012_bib0020","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/j.suronc.2010.10.002","article-title":"Anaphylactic response to blue dye during sentinel lymph node biopsy","volume":"20","author":"Bezu","year":"2011","journal-title":"Surg Oncol"},{"key":"10.1016\/j.clbc.2022.02.012_bib0021","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ejso.2009.10.007","article-title":"Adverse reactions to patent blue V dye - The NEW START and ALMANAC experience","volume":"36","author":"Barthelmes","year":"2010","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clbc.2022.02.012_bib0022","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/anae.12008","article-title":"Anaphylaxis and blue urticaria associated with Patent Blue V injection","volume":"67","author":"Parvaiz","year":"2012","journal-title":"Anaesthesia"},{"key":"10.1016\/j.clbc.2022.02.012_bib0023","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bja.2018.04.014","article-title":"Anaesthesia, surgery, and life-threatening allergic reactions: epidemiology and clinical features of perioperative anaphylaxis in the 6th National Audit Project (NAP6)","volume":"121","author":"Harper","year":"2018","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.clbc.2022.02.012_bib0024","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.ejso.2015.03.197","article-title":"Isotope-only localisation of sentinel lymph node biopsy \u2013 A safe alternative to dual technique","volume":"41","author":"Parvaiz","year":"2015","journal-title":"Eur J Surg Oncol (EJSO)"},{"key":"10.1016\/j.clbc.2022.02.012_bib0025","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"issue":"Suppl 1","key":"10.1016\/j.clbc.2022.02.012_bib0026","first-page":"1","article-title":"Surgical guidelines for the management of breast cancer","volume":"35","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clbc.2022.02.012_bib0027","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000445368","article-title":"The role of blue dye in sentinel node detection for breast cancer: a retrospective study of 203 patients","volume":"11","author":"Garbay","year":"2016","journal-title":"Breast Care (Basel)"},{"key":"10.1016\/j.clbc.2022.02.012_bib0028","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/SLA.0000000000001213","article-title":"The value of isosulfan blue dye in addition to isotope scanning in the identification of the sentinel lymph node in breast cancer patients with a positive lymphoscintigraphy: a randomized controlled trial (ISRCTN98849733)","volume":"262","author":"O'Reilly","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.clbc.2022.02.012_bib0029","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S1072-7515(01)01038-9","article-title":"A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer","volume":"193","author":"Derossis","year":"2001","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.clbc.2022.02.012_bib0030","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S1072-7515(02)01312-1","article-title":"Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid","volume":"195","author":"Kern","year":"2002","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.clbc.2022.02.012_bib0031","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jss.2007.02.054","article-title":"Concordance of peritumoral technetium 99m colloid and subareolar blue dye injection in breast cancer sentinel lymph node biopsy","volume":"143","author":"Kargozaran","year":"2007","journal-title":"J Surg Res"},{"key":"10.1016\/j.clbc.2022.02.012_bib0032","first-page":"30","article-title":"Evaluation of the gamma probe guided sentinel lymph node biopsy and the blue dye technique in the management of breast cancer","volume":"13","author":"Usmani","year":"2010","journal-title":"Hell J Nucl Med"},{"key":"10.1016\/j.clbc.2022.02.012_bib0033","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10549-006-9192-1","article-title":"Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer\u2013results of the ALMANAC validation phase","volume":"99","author":"Goyal","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2022.02.012_bib0034","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10434-001-0013-9","article-title":"Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures","volume":"8","author":"Cody","year":"2001","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2022.02.012_bib0035","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.remn.2009.10.001","article-title":"Factors affecting sentinel lymph node detection failure in breast cancer patients using intradermal injection of the tracer","volume":"29","author":"Abdollahi","year":"2010","journal-title":"Rev Esp Med Nucl"},{"issue":"1","key":"10.1016\/j.clbc.2022.02.012_bib0036","first-page":"30","article-title":"Comparison of pre-operative lymphoscintigraphy with inter-operative gamma probe and dye technique regarding the number of detected sentinel lymph nodes","volume":"12","author":"Sadeghi","year":"2009","journal-title":"Hell J Nucl Med"},{"key":"10.1016\/j.clbc.2022.02.012_bib0037","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s12149-009-0284-y","article-title":"How long the lymphoscintigraphy imaging should be continued for sentinel lymph node mapping?","volume":"23","author":"Sadeghi","year":"2009","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.clbc.2022.02.012_bib0038","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1148\/radiology.220.1.r01jn2347","article-title":"Breast cancer: variables affecting sentinel lymph node visualization at preoperative lymphoscintigraphy","volume":"220","author":"Birdwell","year":"2001","journal-title":"Radiology"},{"key":"10.1016\/j.clbc.2022.02.012_bib0039","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.breast.2007.08.008","article-title":"Factors influencing sentinel lymph node identification failure in breast cancer surgery","volume":"17","author":"Straalman","year":"2008","journal-title":"Breast"},{"key":"10.1016\/j.clbc.2022.02.012_bib0040","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.surg.2005.03.003","article-title":"Factors predicting failure to identify a sentinel lymph node in breast cancer","volume":"138","author":"Chagpar","year":"2005","journal-title":"Surgery"},{"key":"10.1016\/j.clbc.2022.02.012_bib0041","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1046\/j.1524-4741.2003.09205.x","article-title":"Failure to harvest sentinel lymph nodes identified by preoperative lymphoscintigraphy in breast cancer patients","volume":"9","author":"Wu","year":"2003","journal-title":"Breast J"},{"key":"10.1016\/j.clbc.2022.02.012_bib0042","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0748-7983(03)00052-0","article-title":"Learning curve for the detection of axillary sentinel lymph node in breast cancer","volume":"29","author":"Classe","year":"2003","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clbc.2022.02.012_bib0043","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/bjs.9058","article-title":"Results of a national training programme in sentinel lymph node biopsy for breast cancer","volume":"100","author":"Mansel","year":"2013","journal-title":"Br J Surg"},{"key":"10.1016\/j.clbc.2022.02.012_bib0044","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.yasu.2016.03.003","article-title":"Optimal management of the axilla: a look at the evidence","volume":"50","author":"Mamounas","year":"2016","journal-title":"Adv Surg"},{"key":"10.1016\/j.clbc.2022.02.012_bib0045","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12885-016-2137-0","article-title":"The combination of blue dye and radioisotope versus radioisotope alone during sentinel lymph node biopsy for breast cancer: a systematic review","volume":"16","author":"He","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clbc.2022.02.012_bib0046","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/SLA.0b013e3182654494","article-title":"Factors associated with local-regional recurrence after a negative sentinel node dissection: results of the ACOSOG Z0010 trial","volume":"256","author":"Hunt","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.clbc.2022.02.012_bib0047","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejso.2011.10.003","article-title":"Sentinel lymph node biopsy after previous axillary surgery: a review","volume":"38","author":"Kothari","year":"2012","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clbc.2022.02.012_bib0048","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.clbc.2022.02.012_bib0049","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/bjs.10411","article-title":"Swedish Breast Cancer G, the Swedish Society of Breast S. Ten-year report on axillary recurrence after negative sentinel node biopsy for breast cancer from the Swedish Multicentre Cohort Study","volume":"104","author":"de Boniface","year":"2017","journal-title":"Br J Surg"},{"key":"10.1016\/j.clbc.2022.02.012_bib0050","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1186\/s12885-017-3361-y","article-title":"Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial","volume":"17","author":"de Boniface","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clbc.2022.02.012_bib0051","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial","volume":"11","author":"Krag","year":"2010","journal-title":"Lancet Oncol"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820922000465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820922000465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:22:21Z","timestamp":1761513741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820922000465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S1526820922000465"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2022.02.012","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isotope-Only Localization for Sentinel Lymph Node Biopsy - Medium-Term Oncological Outcomes","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2022.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}